Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 17.42
+0.35 (2.05%)
Jul 31, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 9.01 billion as of July 31, 2026. Its market cap has decreased by -10.82% in one year.
Market Cap
9.01B
Enterprise Value
7.07B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.42
ChartMarket Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 9.01B, a decrease of -73.62%. That is a compound annual growth rate of -24.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 9.01B | 13.10% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 9.91B |
| GemPharmatech | 9.88B |
| Shanghai Medicilon | 9.63B |
| Beijing Hotgen Biotech | 9.48B |
| Jiangxi Fushine Pharmaceutical | 8.84B |
| Chengdu Olymvax Biopharmaceuticals | 8.75B |
| Vcanbio Cell & Gene Engineering Corp., | 8.56B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.40B |